GoodRx Holdings, Inc. GDRX Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by GoodRx Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about GoodRx Holdings, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GoodRx Holdings, Inc.'s financing cash flow?
- GoodRx Holdings, Inc. (GDRX) reported financing cash flow of -$16.3M in Q1 2026.
- How has GoodRx Holdings, Inc.'s financing cash flow changed year-over-year?
- GoodRx Holdings, Inc.'s financing cash flow increased by 84.5% year-over-year, from -$104.9M to -$16.3M.
- What is the long-term trend for GoodRx Holdings, Inc.'s financing cash flow?
- Over 4 years (2021 to 2025), GoodRx Holdings, Inc.'s financing cash flow has grown at a 66.5% compound annual growth rate (CAGR), from -$30.53M to -$234.47M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.